(FILES) A picture taken on February 4, 2022 shows a screen bearing the new logo of French pharmaceutical group Sanofi which is presented on the day of the group's 2021 full year results at Sanofi headquarters in Paris. Emmanuel Macron said on October 14, 2024 that the government had "the instruments to ensure that France is protected" in the face of the expected arrival of a new American shareholder in a Sanofi group entity marketing Doliprane, relaunching the debate on the risks to the country's supply of medicines. (Photo by Eric PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)